DNTH vs FAST · rev $6.2M vs P/E 43, rev $7.55B
Dianthus Therapeutics Inc. (DNTH) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
DNTH currently screens at market cap $4.40B. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the DNTH and FAST stock pages for the full models.
Not investment advice.